e-learning
resources
Paris 2018
Monday, 17.09.2018
New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Mid-term clinical course of the three Japanese SFTPC mutated familial interstitial pneumonia patients.
H. Ito (Nagasaki, Japan), H. Nakaoka (Nagasaki, Japan), Y. Yamashita (Nagasaki, Japan), M. Takaki (Nagasaki, Japan), T. Tanaka (Nagasaki, Japan), M. Ishida (Kochi, Japan), K. Morimoto (Nagasaki, Japan)
Source:
International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Session:
New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Session type:
Poster Discussion
Number:
2234
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Ito (Nagasaki, Japan), H. Nakaoka (Nagasaki, Japan), Y. Yamashita (Nagasaki, Japan), M. Takaki (Nagasaki, Japan), T. Tanaka (Nagasaki, Japan), M. Ishida (Kochi, Japan), K. Morimoto (Nagasaki, Japan). Mid-term clinical course of the three Japanese SFTPC mutated familial interstitial pneumonia patients.. 2234
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
Variants of the clinical course of familial pulmonary sarcoidosis
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019
Genotype alone does not predict the clinical course of SFTPC deficiency in paediatric patients
Source: Eur Respir J 2015; 46: 197-206
Year: 2015
Clinical course of suspected familial versus sporadic IPFData from the PROOF-Next IPF registry
Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis
Year: 2021
TERT/TERC mutations in a Greek cohort of suspected genetic pulmonary fibrosis patients
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018
Functional assessment of newly identified SFTPA1 and SFTPA2 mutations in patients with idiopathic interstitial pneumonia (IIP) and lung cancer
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018
Telomere-Related Gene mutations in a Greek cohort of suspected monogenic pulmonary fibrosis patients
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
Sftpc mutations are a common cause of adult familial idiopathic interstitial pneumonia
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009
Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study
Source: Eur Respir J 2012; 40: 101-109
Year: 2012
The comparison of sarcoidosis patients with benign and recurrent clinical course of the disease
Source: Eur Respir J 2005; 26: Suppl. 49, 331s
Year: 2005
Comparison of clinical features between patients of lung cancer with combined pulmonary fibrosis and emphysema syndrome and those with interstitial pneumonia
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012
Healthy survivor bias in patients with idiopathic pulmonary fibrosis in clinical registries.
Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia
Year: 2021
Genetics variants in familial interstitial pneumonia and progressive fibrosing interstitial lung disease (PF-ILD)
Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis
Year: 2021
PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Interstitial lung disease caused by filamin A gene mutations: Clinical course of three paediatric cases
Source: International Congress 2016 – Orphan diseases II
Year: 2016
A cohort of patients with a progressive fibrosing phenotype of interstitial lung disease (PF-ILD) other than idiopathic pulmonary fibrosis (IPF): the PROGRESS study
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
Familial interstitial lung disease and ABCA3 gene Gly964Asp mutation
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010
MUC5B gene in a cohort of Lebanese patients with idiopathic pulmonary fibrosis
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018
Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry
Source: Eur Respir J 2015; 46: 186-196
Year: 2015
Baseline characteristics and survival of patients with idiopathic pulmonary fibrosis (IPF): analysis from the Swedish IPF registry
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020
Interstitial lung disease with ANCA-associated vasculitis (AAV-ILD): Clinical features and survival compared to patients with ILD associated with systemic sclerosis and IPF
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept